Management of Ammonia Level 115 µg/dL
For an ammonia level of 115 µg/dL (approximately 68 µmol/L), initiate medical management with nitrogen-scavenging agents (sodium benzoate, sodium phenylacetate, or lactulose), stop protein intake temporarily, reverse catabolism, and aggressively investigate for precipitating factors—this level does NOT require dialysis unless there is rapidly deteriorating neurological status or encephalopathy. 11
Clinical Context and Risk Assessment
An ammonia level of 115 µg/dL falls into a moderate elevation range that requires immediate attention but typically does not mandate kidney replacement therapy (KRT). The critical thresholds to understand are:
- >150 µg/dL (>256 µmol/L): Consider CKRT if rapidly deteriorating neurological status, coma, or cerebral edema present 111
- >200 µg/dL: Strongly associated with cerebral herniation risk 2
- >300 µg/dL (>511 µmol/L): Rapid rise within hours warrants KRT if uncontrolled by medical therapy 11
- >400 µg/dL (>681 µmol/L): Persistently high levels refractory to medical measures require KRT 11
Your patient at 115 µg/dL is below these critical thresholds, making medical management the appropriate first-line approach.
Immediate Assessment Priorities
Neurological Status Evaluation
Assess for encephalopathy grade immediately:
- Grade 0-I: Alert, mild confusion → outpatient/ward management possible
- Grade II: Lethargy, disorientation → close monitoring required
- Grade III-IV: Stupor, coma → ICU admission mandatory 3
Key point: The duration of hyperammonemic coma is the most important prognostic factor—not the ammonia level itself or rate of clearance 11. Early intervention prevents irreversible neurological damage.
Identify Precipitating Factors
Look specifically for:
- Infections (most common precipitant)
- GI bleeding (blood in gut increases ammonia production)
- Constipation (increases ammonia absorption)
- Medications: valproate, carbamazepine, chemotherapy agents
- Dehydration/electrolyte disorders (hypokalemia, alkalosis)
- Protein overload in diet
- Underlying liver disease vs. urea cycle disorder (especially if first episode or no known liver disease) 34
First-Line Medical Management
Nitrogen-Scavenging Therapy
Initiate immediately at ammonia >150 µmol/L (>255 µg/dL), but reasonable to start at your level of 115 µg/dL given proximity to threshold 1:
Options:
- Sodium benzoate + sodium phenylacetate (IV): Can be administered more rapidly than KRT; conjugates with glycine and glutamine to create excretable compounds
- Lactulose: 20-30g orally or via NG tube every 2-4 hours, titrate to 2-3 soft stools daily 53
- Polyethylene glycol: Alternative if risk of ileus/abdominal distention 3
Important caveat: While lactulose is widely used, evidence in acute liver failure shows only modest benefit with small increase in survival time but no difference in encephalopathy severity 2. However, it remains standard of care for hepatic encephalopathy.
Nutritional Management
- Stop protein intake temporarily (24-48 hours maximum)
- Provide adequate calories (glucose infusion) to prevent catabolism—catabolism worsens hyperammonemia
- Resume protein gradually at 0.5-1.0 g/kg/day once ammonia declining 4
Supportive Care
- Correct electrolyte abnormalities (especially hypokalemia, alkalosis)
- Treat infections empirically if suspected
- Avoid sedatives/benzodiazepines unless absolutely necessary
- Monitor glucose closely (hypoglycemia common)
When to Escalate to Dialysis
CKRT (continuous kidney replacement therapy) is NOT indicated at 115 µg/dL unless:
- Rapidly deteriorating neurological status develops
- Patient progresses to coma or cerebral edema
- Ammonia rises rapidly to >300 µg/dL within hours despite medical therapy
- Ammonia remains persistently >400 µg/dL refractory to medical measures 111
If dialysis becomes necessary, high-dose CVVHD (continuous venovenous hemodialysis) is the preferred first-line KRT modality when feasible, as it provides superior ammonia clearance with fewer hemodynamic complications and less rebound hyperammonemia compared to intermittent HD 111.
Monitoring Strategy
Serial ammonia measurements:
- Every 2-4 hours initially until declining trend established
- Target: <200 µmol/L (<341 µg/dL) for step-down therapy 11
Neurological checks:
- Hourly mental status assessments
- Watch for signs of increased intracranial pressure: headache, vomiting, bradycardia, pupillary changes
Common pitfall: Routine ammonia testing in all confused patients is NOT recommended—it should be reserved for unexplained encephalopathy, first episodes, or when diagnosis unclear 36. However, once hyperammonemia is confirmed, serial monitoring is essential.
Special Considerations
If No Known Liver Disease
Consider urea cycle disorder, especially if:
- First episode of unexplained encephalopathy
- Young adult or pediatric patient
- Family history of unexplained neurological events
- Respiratory alkalosis present (compensatory hyperventilation)
These patients may deteriorate rapidly and require more aggressive management 78.
If Cirrhosis Present
Cirrhotic patients tolerate higher ammonia levels better than those with acute metabolic causes. Focus on:
- Treating precipitants (infection, bleeding, constipation)
- Lactulose as mainstay
- Consider rifaximin 550mg BID as add-on therapy for recurrent episodes 53
Summary Algorithm
At ammonia 115 µg/dL:
- Assess neurological status → If Grade III-IV, ICU admission
- Identify and treat precipitants → Infection, bleeding, constipation, medications
- Start nitrogen scavengers → Lactulose or IV sodium benzoate/phenylacetate
- Nutritional support → Stop protein temporarily, provide glucose
- Monitor closely → Serial ammonia q2-4h, neurological checks hourly
- Escalate to CKRT only if → Deteriorating status, rising levels >300 µg/dL, or refractory to medical therapy
The key is aggressive medical management NOW to prevent progression to levels requiring dialysis, while maintaining vigilance for neurological deterioration that would mandate ICU-level care and potential KRT.